This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/517837-ema-covid19-johnson-jab-coronavirus/
The article has changed 4 times. There is an RSS feed of changes available.
| Version 1 | Version 2 |
|---|---|
| European Medicines Agency gives green light to Johnson & Johnson's one-shot Covid-19 jab | European Medicines Agency gives green light to Johnson & Johnson's one-shot Covid-19 jab |
| (6 months later) | |
| The EU’s drug regulator has given its backing to the Covid-19 vaccine produced by American pharma giant Johnson & Johnson. The single-shot vaccine has also been approved by the EU, meaning it can now be rolled out in the bloc. | The EU’s drug regulator has given its backing to the Covid-19 vaccine produced by American pharma giant Johnson & Johnson. The single-shot vaccine has also been approved by the EU, meaning it can now be rolled out in the bloc. |
| On Thursday, Johnson & Johnson’s vaccine became the fourth to be recommended to the EU by the European Medicines Agency (EMA), after the jabs developed by Pfizer, Moderna, and AstraZeneca. | On Thursday, Johnson & Johnson’s vaccine became the fourth to be recommended to the EU by the European Medicines Agency (EMA), after the jabs developed by Pfizer, Moderna, and AstraZeneca. |
| “With this latest positive opinion, authorities across the European Union will have another option to combat the pandemic and protect the lives and health of their citizens,” said Emer Cooke, the EMA’s executive director. “This is the first vaccine which can be used as a single dose.” | “With this latest positive opinion, authorities across the European Union will have another option to combat the pandemic and protect the lives and health of their citizens,” said Emer Cooke, the EMA’s executive director. “This is the first vaccine which can be used as a single dose.” |
| Following the EMA’s decision earlier Thursday, the European Commission just hours later granted a conditional marketing authorization for the J&J jab – the next step in a vaccine’s rollout before EU member states can access bloc-secured doses or purchase more. | Following the EMA’s decision earlier Thursday, the European Commission just hours later granted a conditional marketing authorization for the J&J jab – the next step in a vaccine’s rollout before EU member states can access bloc-secured doses or purchase more. |
| The bloc’s contract with Janssen, signed in October, is for an initial 200 million doses in the second quarter of 2021, with the option for governments to purchase another 200 million doses. | The bloc’s contract with Janssen, signed in October, is for an initial 200 million doses in the second quarter of 2021, with the option for governments to purchase another 200 million doses. |
| The EMA noted that the single-shot jab was found to be 67 percent effective in reducing symptomatic Covid-19 cases two weeks after the vaccine was administered. | The EMA noted that the single-shot jab was found to be 67 percent effective in reducing symptomatic Covid-19 cases two weeks after the vaccine was administered. |
| The firm’s study involved more than 44,000 people, registering 116 infections out of 19,630 people who received the vaccine, compared with 348 cases in the 19,691 people who were given a placebo. The jab’s side effects were considered mild or moderate and usually subsided within a few days. | The firm’s study involved more than 44,000 people, registering 116 infections out of 19,630 people who received the vaccine, compared with 348 cases in the 19,691 people who were given a placebo. The jab’s side effects were considered mild or moderate and usually subsided within a few days. |
| The news comes as a number of countries around the EU have suspended their use of the AstraZeneca vaccine after a number of recipients developed blood clots. The EMA and the UK have dismissed the link with the vaccine, but further investigations are being carried out. | The news comes as a number of countries around the EU have suspended their use of the AstraZeneca vaccine after a number of recipients developed blood clots. The EMA and the UK have dismissed the link with the vaccine, but further investigations are being carried out. |
| Like this story? Share it with a friend! | Like this story? Share it with a friend! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |